nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—CYP2C9—Estropipate—osteoporosis	0.0699	0.122	CbGbCtD
Trimipramine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0437	0.0761	CbGbCtD
Trimipramine—CYP2C19—Cholecalciferol—osteoporosis	0.0433	0.0754	CbGbCtD
Trimipramine—CYP3A4—Estropipate—osteoporosis	0.0407	0.0708	CbGbCtD
Trimipramine—CYP3A4—Calcitriol—osteoporosis	0.0407	0.0708	CbGbCtD
Trimipramine—CYP2C9—Cholecalciferol—osteoporosis	0.036	0.0627	CbGbCtD
Trimipramine—CYP2C19—Estradiol—osteoporosis	0.0349	0.0608	CbGbCtD
Trimipramine—CYP2D6—Cholecalciferol—osteoporosis	0.0329	0.0573	CbGbCtD
Trimipramine—CYP3A4—Ergocalciferol—osteoporosis	0.0325	0.0566	CbGbCtD
Trimipramine—ABCB1—Conjugated Estrogens—osteoporosis	0.0321	0.0559	CbGbCtD
Trimipramine—CYP2C9—Estradiol—osteoporosis	0.029	0.0505	CbGbCtD
Trimipramine—ABCB1—Estradiol—osteoporosis	0.0282	0.0491	CbGbCtD
Trimipramine—CYP3A4—Raloxifene—osteoporosis	0.0271	0.0472	CbGbCtD
Trimipramine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0262	0.0456	CbGbCtD
Trimipramine—CYP3A4—Cholecalciferol—osteoporosis	0.021	0.0365	CbGbCtD
Trimipramine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0192	0.0335	CbGbCtD
Trimipramine—CYP3A4—Estradiol—osteoporosis	0.0169	0.0294	CbGbCtD
Trimipramine—Benazepril—MTHFR—osteoporosis	0.00122	0.47	CrCbGaD
Trimipramine—Benazepril—ACE—osteoporosis	0.000993	0.383	CrCbGaD
Trimipramine—Dyspepsia—Ibandronate—osteoporosis	0.000677	0.00211	CcSEcCtD
Trimipramine—Anxiety—Ethinyl Estradiol—osteoporosis	0.000676	0.00211	CcSEcCtD
Trimipramine—Constipation—Alendronate—osteoporosis	0.000676	0.00211	CcSEcCtD
Trimipramine—Hypertension—Risedronate—osteoporosis	0.000671	0.00209	CcSEcCtD
Trimipramine—Discomfort—Ethinyl Estradiol—osteoporosis	0.00067	0.00209	CcSEcCtD
Trimipramine—Somnolence—Calcitriol—osteoporosis	0.000669	0.00209	CcSEcCtD
Trimipramine—Decreased appetite—Ibandronate—osteoporosis	0.000669	0.00209	CcSEcCtD
Trimipramine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000666	0.00208	CcSEcCtD
Trimipramine—Malaise—Pamidronate—osteoporosis	0.000666	0.00208	CcSEcCtD
Trimipramine—Fatigue—Ibandronate—osteoporosis	0.000663	0.00207	CcSEcCtD
Trimipramine—Dysgeusia—Zoledronate—osteoporosis	0.00066	0.00206	CcSEcCtD
Trimipramine—Alopecia—Conjugated Estrogens—osteoporosis	0.000659	0.00206	CcSEcCtD
Trimipramine—Anxiety—Risedronate—osteoporosis	0.000659	0.00206	CcSEcCtD
Trimipramine—Constipation—Ibandronate—osteoporosis	0.000658	0.00205	CcSEcCtD
Trimipramine—Pruritus—Etidronic acid—osteoporosis	0.000656	0.00205	CcSEcCtD
Trimipramine—Acute coronary syndrome—Estradiol—osteoporosis	0.000656	0.00205	CcSEcCtD
Trimipramine—Decreased appetite—Calcitriol—osteoporosis	0.000655	0.00204	CcSEcCtD
Trimipramine—Neuropathy peripheral—Estradiol—osteoporosis	0.000652	0.00203	CcSEcCtD
Trimipramine—Myocardial infarction—Estradiol—osteoporosis	0.000652	0.00203	CcSEcCtD
Trimipramine—Feeling abnormal—Alendronate—osteoporosis	0.000651	0.00203	CcSEcCtD
Trimipramine—Oedema—Ethinyl Estradiol—osteoporosis	0.00065	0.00203	CcSEcCtD
Trimipramine—Jaundice—Estradiol—osteoporosis	0.000648	0.00202	CcSEcCtD
Trimipramine—Dry mouth—Risedronate—osteoporosis	0.000647	0.00202	CcSEcCtD
Trimipramine—Constipation—Calcitriol—osteoporosis	0.000644	0.00201	CcSEcCtD
Trimipramine—Convulsion—Pamidronate—osteoporosis	0.00064	0.002	CcSEcCtD
Trimipramine—Hypertension—Pamidronate—osteoporosis	0.000637	0.00199	CcSEcCtD
Trimipramine—Urticaria—Estropipate—osteoporosis	0.000637	0.00199	CcSEcCtD
Trimipramine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000636	0.00198	CcSEcCtD
Trimipramine—Vision blurred—Zoledronate—osteoporosis	0.000636	0.00198	CcSEcCtD
Trimipramine—Diarrhoea—Etidronic acid—osteoporosis	0.000634	0.00198	CcSEcCtD
Trimipramine—Abdominal pain—Estropipate—osteoporosis	0.000634	0.00198	CcSEcCtD
Trimipramine—Body temperature increased—Estropipate—osteoporosis	0.000634	0.00198	CcSEcCtD
Trimipramine—Feeling abnormal—Ibandronate—osteoporosis	0.000634	0.00198	CcSEcCtD
Trimipramine—Tremor—Zoledronate—osteoporosis	0.000632	0.00197	CcSEcCtD
Trimipramine—Urticaria—Alendronate—osteoporosis	0.000628	0.00196	CcSEcCtD
Trimipramine—Anxiety—Pamidronate—osteoporosis	0.000626	0.00196	CcSEcCtD
Trimipramine—Ill-defined disorder—Zoledronate—osteoporosis	0.000626	0.00195	CcSEcCtD
Trimipramine—Abdominal pain—Alendronate—osteoporosis	0.000625	0.00195	CcSEcCtD
Trimipramine—Body temperature increased—Alendronate—osteoporosis	0.000625	0.00195	CcSEcCtD
Trimipramine—Discomfort—Pamidronate—osteoporosis	0.000621	0.00194	CcSEcCtD
Trimipramine—Agitation—Zoledronate—osteoporosis	0.00062	0.00193	CcSEcCtD
Trimipramine—Abdominal pain—Raloxifene—osteoporosis	0.000614	0.00192	CcSEcCtD
Trimipramine—Body temperature increased—Raloxifene—osteoporosis	0.000614	0.00192	CcSEcCtD
Trimipramine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000612	0.00191	CcSEcCtD
Trimipramine—Urticaria—Ibandronate—osteoporosis	0.000611	0.00191	CcSEcCtD
Trimipramine—Malaise—Zoledronate—osteoporosis	0.000608	0.0019	CcSEcCtD
Trimipramine—Abdominal pain—Ibandronate—osteoporosis	0.000608	0.0019	CcSEcCtD
Trimipramine—Body temperature increased—Ibandronate—osteoporosis	0.000608	0.0019	CcSEcCtD
Trimipramine—Confusional state—Pamidronate—osteoporosis	0.000608	0.0019	CcSEcCtD
Trimipramine—Oedema—Pamidronate—osteoporosis	0.000603	0.00188	CcSEcCtD
Trimipramine—Urticaria—Calcitriol—osteoporosis	0.000598	0.00187	CcSEcCtD
Trimipramine—Palpitations—Zoledronate—osteoporosis	0.000596	0.00186	CcSEcCtD
Trimipramine—Abdominal pain—Calcitriol—osteoporosis	0.000595	0.00186	CcSEcCtD
Trimipramine—Body temperature increased—Calcitriol—osteoporosis	0.000595	0.00186	CcSEcCtD
Trimipramine—Hypoaesthesia—Estradiol—osteoporosis	0.000594	0.00185	CcSEcCtD
Trimipramine—Thrombocytopenia—Pamidronate—osteoporosis	0.00059	0.00184	CcSEcCtD
Trimipramine—Vomiting—Etidronic acid—osteoporosis	0.00059	0.00184	CcSEcCtD
Trimipramine—Tachycardia—Pamidronate—osteoporosis	0.000588	0.00184	CcSEcCtD
Trimipramine—Rash—Etidronic acid—osteoporosis	0.000585	0.00182	CcSEcCtD
Trimipramine—Convulsion—Zoledronate—osteoporosis	0.000584	0.00182	CcSEcCtD
Trimipramine—Dermatitis—Etidronic acid—osteoporosis	0.000584	0.00182	CcSEcCtD
Trimipramine—Hypertension—Zoledronate—osteoporosis	0.000582	0.00182	CcSEcCtD
Trimipramine—Headache—Etidronic acid—osteoporosis	0.000581	0.00181	CcSEcCtD
Trimipramine—Asthenia—Estropipate—osteoporosis	0.000575	0.0018	CcSEcCtD
Trimipramine—Anorexia—Pamidronate—osteoporosis	0.000574	0.00179	CcSEcCtD
Trimipramine—Palpitations—Conjugated Estrogens—osteoporosis	0.000574	0.00179	CcSEcCtD
Trimipramine—Insomnia—Risedronate—osteoporosis	0.000573	0.00179	CcSEcCtD
Trimipramine—Anxiety—Zoledronate—osteoporosis	0.000572	0.00179	CcSEcCtD
Trimipramine—Paraesthesia—Risedronate—osteoporosis	0.000569	0.00178	CcSEcCtD
Trimipramine—Pruritus—Estropipate—osteoporosis	0.000567	0.00177	CcSEcCtD
Trimipramine—Discomfort—Zoledronate—osteoporosis	0.000567	0.00177	CcSEcCtD
Trimipramine—Asthenia—Alendronate—osteoporosis	0.000567	0.00177	CcSEcCtD
Trimipramine—Hypotension—Pamidronate—osteoporosis	0.000563	0.00176	CcSEcCtD
Trimipramine—Convulsion—Conjugated Estrogens—osteoporosis	0.000563	0.00176	CcSEcCtD
Trimipramine—Dry mouth—Zoledronate—osteoporosis	0.000562	0.00175	CcSEcCtD
Trimipramine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000561	0.00175	CcSEcCtD
Trimipramine—Pruritus—Alendronate—osteoporosis	0.000559	0.00174	CcSEcCtD
Trimipramine—Dyspepsia—Risedronate—osteoporosis	0.000558	0.00174	CcSEcCtD
Trimipramine—Tinnitus—Estradiol—osteoporosis	0.000557	0.00174	CcSEcCtD
Trimipramine—Constipation—Ethinyl Estradiol—osteoporosis	0.000556	0.00174	CcSEcCtD
Trimipramine—Confusional state—Zoledronate—osteoporosis	0.000555	0.00173	CcSEcCtD
Trimipramine—Flushing—Estradiol—osteoporosis	0.000554	0.00173	CcSEcCtD
Trimipramine—Asthenia—Ibandronate—osteoporosis	0.000552	0.00172	CcSEcCtD
Trimipramine—Anxiety—Conjugated Estrogens—osteoporosis	0.000551	0.00172	CcSEcCtD
Trimipramine—Nausea—Etidronic acid—osteoporosis	0.000551	0.00172	CcSEcCtD
Trimipramine—Oedema—Zoledronate—osteoporosis	0.00055	0.00172	CcSEcCtD
Trimipramine—Diarrhoea—Estropipate—osteoporosis	0.000549	0.00171	CcSEcCtD
Trimipramine—Fatigue—Risedronate—osteoporosis	0.000547	0.00171	CcSEcCtD
Trimipramine—Insomnia—Pamidronate—osteoporosis	0.000545	0.0017	CcSEcCtD
Trimipramine—Pruritus—Ibandronate—osteoporosis	0.000544	0.0017	CcSEcCtD
Trimipramine—Constipation—Risedronate—osteoporosis	0.000542	0.00169	CcSEcCtD
Trimipramine—Paraesthesia—Pamidronate—osteoporosis	0.000541	0.00169	CcSEcCtD
Trimipramine—Diarrhoea—Alendronate—osteoporosis	0.000541	0.00169	CcSEcCtD
Trimipramine—Asthenia—Calcitriol—osteoporosis	0.00054	0.00169	CcSEcCtD
Trimipramine—Thrombocytopenia—Zoledronate—osteoporosis	0.000539	0.00168	CcSEcCtD
Trimipramine—Tachycardia—Zoledronate—osteoporosis	0.000537	0.00168	CcSEcCtD
Trimipramine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000536	0.00167	CcSEcCtD
Trimipramine—Somnolence—Pamidronate—osteoporosis	0.000536	0.00167	CcSEcCtD
Trimipramine—Pruritus—Calcitriol—osteoporosis	0.000533	0.00166	CcSEcCtD
Trimipramine—Diarrhoea—Raloxifene—osteoporosis	0.000532	0.00166	CcSEcCtD
Trimipramine—Dyspepsia—Pamidronate—osteoporosis	0.00053	0.00166	CcSEcCtD
Trimipramine—Dizziness—Estropipate—osteoporosis	0.00053	0.00166	CcSEcCtD
Trimipramine—Oedema—Conjugated Estrogens—osteoporosis	0.00053	0.00165	CcSEcCtD
Trimipramine—Alopecia—Estradiol—osteoporosis	0.000528	0.00165	CcSEcCtD
Trimipramine—Diarrhoea—Ibandronate—osteoporosis	0.000526	0.00164	CcSEcCtD
Trimipramine—Anorexia—Zoledronate—osteoporosis	0.000525	0.00164	CcSEcCtD
Trimipramine—Decreased appetite—Pamidronate—osteoporosis	0.000524	0.00163	CcSEcCtD
Trimipramine—Dizziness—Alendronate—osteoporosis	0.000522	0.00163	CcSEcCtD
Trimipramine—Fatigue—Pamidronate—osteoporosis	0.00052	0.00162	CcSEcCtD
Trimipramine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000517	0.00161	CcSEcCtD
Trimipramine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000516	0.00161	CcSEcCtD
Trimipramine—Constipation—Pamidronate—osteoporosis	0.000515	0.00161	CcSEcCtD
Trimipramine—Diarrhoea—Calcitriol—osteoporosis	0.000515	0.00161	CcSEcCtD
Trimipramine—Hypotension—Zoledronate—osteoporosis	0.000514	0.00161	CcSEcCtD
Trimipramine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000514	0.0016	CcSEcCtD
Trimipramine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000514	0.0016	CcSEcCtD
Trimipramine—Dizziness—Raloxifene—osteoporosis	0.000514	0.0016	CcSEcCtD
Trimipramine—Vomiting—Estropipate—osteoporosis	0.00051	0.00159	CcSEcCtD
Trimipramine—Dysgeusia—Estradiol—osteoporosis	0.000509	0.00159	CcSEcCtD
Trimipramine—Dizziness—Ibandronate—osteoporosis	0.000509	0.00159	CcSEcCtD
Trimipramine—Rash—Estropipate—osteoporosis	0.000506	0.00158	CcSEcCtD
Trimipramine—Dermatitis—Estropipate—osteoporosis	0.000505	0.00158	CcSEcCtD
Trimipramine—Anorexia—Conjugated Estrogens—osteoporosis	0.000505	0.00158	CcSEcCtD
Trimipramine—Urticaria—Risedronate—osteoporosis	0.000504	0.00157	CcSEcCtD
Trimipramine—Headache—Estropipate—osteoporosis	0.000502	0.00157	CcSEcCtD
Trimipramine—Vomiting—Alendronate—osteoporosis	0.000502	0.00157	CcSEcCtD
Trimipramine—Body temperature increased—Risedronate—osteoporosis	0.000501	0.00156	CcSEcCtD
Trimipramine—Abdominal pain—Risedronate—osteoporosis	0.000501	0.00156	CcSEcCtD
Trimipramine—Rash—Alendronate—osteoporosis	0.000498	0.00155	CcSEcCtD
Trimipramine—Insomnia—Zoledronate—osteoporosis	0.000498	0.00155	CcSEcCtD
Trimipramine—Dermatitis—Alendronate—osteoporosis	0.000498	0.00155	CcSEcCtD
Trimipramine—Feeling abnormal—Pamidronate—osteoporosis	0.000497	0.00155	CcSEcCtD
Trimipramine—Hypotension—Conjugated Estrogens—osteoporosis	0.000495	0.00155	CcSEcCtD
Trimipramine—Headache—Alendronate—osteoporosis	0.000495	0.00154	CcSEcCtD
Trimipramine—Paraesthesia—Zoledronate—osteoporosis	0.000494	0.00154	CcSEcCtD
Trimipramine—Vomiting—Raloxifene—osteoporosis	0.000494	0.00154	CcSEcCtD
Trimipramine—Rash—Raloxifene—osteoporosis	0.00049	0.00153	CcSEcCtD
Trimipramine—Dermatitis—Raloxifene—osteoporosis	0.000489	0.00153	CcSEcCtD
Trimipramine—Somnolence—Zoledronate—osteoporosis	0.000489	0.00153	CcSEcCtD
Trimipramine—Vomiting—Ibandronate—osteoporosis	0.000489	0.00153	CcSEcCtD
Trimipramine—Tremor—Estradiol—osteoporosis	0.000487	0.00152	CcSEcCtD
Trimipramine—Headache—Raloxifene—osteoporosis	0.000487	0.00152	CcSEcCtD
Trimipramine—Rash—Ibandronate—osteoporosis	0.000485	0.00151	CcSEcCtD
Trimipramine—Dermatitis—Ibandronate—osteoporosis	0.000485	0.00151	CcSEcCtD
Trimipramine—Dyspepsia—Zoledronate—osteoporosis	0.000485	0.00151	CcSEcCtD
Trimipramine—Ill-defined disorder—Estradiol—osteoporosis	0.000482	0.00151	CcSEcCtD
Trimipramine—Headache—Ibandronate—osteoporosis	0.000482	0.0015	CcSEcCtD
Trimipramine—Insomnia—Conjugated Estrogens—osteoporosis	0.000479	0.0015	CcSEcCtD
Trimipramine—Vomiting—Calcitriol—osteoporosis	0.000479	0.00149	CcSEcCtD
Trimipramine—Decreased appetite—Zoledronate—osteoporosis	0.000478	0.00149	CcSEcCtD
Trimipramine—Agitation—Estradiol—osteoporosis	0.000478	0.00149	CcSEcCtD
Trimipramine—Nausea—Estropipate—osteoporosis	0.000476	0.00149	CcSEcCtD
Trimipramine—Abdominal pain—Pamidronate—osteoporosis	0.000476	0.00149	CcSEcCtD
Trimipramine—Body temperature increased—Pamidronate—osteoporosis	0.000476	0.00149	CcSEcCtD
Trimipramine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000476	0.00149	CcSEcCtD
Trimipramine—Rash—Calcitriol—osteoporosis	0.000475	0.00148	CcSEcCtD
Trimipramine—Fatigue—Zoledronate—osteoporosis	0.000475	0.00148	CcSEcCtD
Trimipramine—Dermatitis—Calcitriol—osteoporosis	0.000474	0.00148	CcSEcCtD
Trimipramine—Headache—Calcitriol—osteoporosis	0.000472	0.00147	CcSEcCtD
Trimipramine—Somnolence—Conjugated Estrogens—osteoporosis	0.000471	0.00147	CcSEcCtD
Trimipramine—Constipation—Zoledronate—osteoporosis	0.000471	0.00147	CcSEcCtD
Trimipramine—Nausea—Alendronate—osteoporosis	0.000469	0.00146	CcSEcCtD
Trimipramine—Malaise—Estradiol—osteoporosis	0.000469	0.00146	CcSEcCtD
Trimipramine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000467	0.00146	CcSEcCtD
Trimipramine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000466	0.00146	CcSEcCtD
Trimipramine—Nausea—Raloxifene—osteoporosis	0.000462	0.00144	CcSEcCtD
Trimipramine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000461	0.00144	CcSEcCtD
Trimipramine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00046	0.00144	CcSEcCtD
Trimipramine—Palpitations—Estradiol—osteoporosis	0.000459	0.00143	CcSEcCtD
Trimipramine—Fatigue—Conjugated Estrogens—osteoporosis	0.000457	0.00143	CcSEcCtD
Trimipramine—Nausea—Ibandronate—osteoporosis	0.000457	0.00143	CcSEcCtD
Trimipramine—Asthenia—Risedronate—osteoporosis	0.000455	0.00142	CcSEcCtD
Trimipramine—Feeling abnormal—Zoledronate—osteoporosis	0.000454	0.00142	CcSEcCtD
Trimipramine—Constipation—Conjugated Estrogens—osteoporosis	0.000453	0.00141	CcSEcCtD
Trimipramine—Hypertension—Estradiol—osteoporosis	0.000449	0.0014	CcSEcCtD
Trimipramine—Pruritus—Risedronate—osteoporosis	0.000448	0.0014	CcSEcCtD
Trimipramine—Nausea—Calcitriol—osteoporosis	0.000447	0.0014	CcSEcCtD
Trimipramine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000445	0.00139	CcSEcCtD
Trimipramine—Anxiety—Estradiol—osteoporosis	0.000441	0.00138	CcSEcCtD
Trimipramine—Urticaria—Zoledronate—osteoporosis	0.000437	0.00136	CcSEcCtD
Trimipramine—Discomfort—Estradiol—osteoporosis	0.000437	0.00136	CcSEcCtD
Trimipramine—Abdominal pain—Zoledronate—osteoporosis	0.000435	0.00136	CcSEcCtD
Trimipramine—Body temperature increased—Zoledronate—osteoporosis	0.000435	0.00136	CcSEcCtD
Trimipramine—Diarrhoea—Risedronate—osteoporosis	0.000434	0.00135	CcSEcCtD
Trimipramine—Dry mouth—Estradiol—osteoporosis	0.000433	0.00135	CcSEcCtD
Trimipramine—Asthenia—Pamidronate—osteoporosis	0.000432	0.00135	CcSEcCtD
Trimipramine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00043	0.00134	CcSEcCtD
Trimipramine—Confusional state—Estradiol—osteoporosis	0.000428	0.00133	CcSEcCtD
Trimipramine—Pruritus—Pamidronate—osteoporosis	0.000426	0.00133	CcSEcCtD
Trimipramine—Oedema—Estradiol—osteoporosis	0.000424	0.00132	CcSEcCtD
Trimipramine—Urticaria—Conjugated Estrogens—osteoporosis	0.000421	0.00131	CcSEcCtD
Trimipramine—Dizziness—Risedronate—osteoporosis	0.000419	0.00131	CcSEcCtD
Trimipramine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000419	0.00131	CcSEcCtD
Trimipramine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000419	0.00131	CcSEcCtD
Trimipramine—Tachycardia—Estradiol—osteoporosis	0.000414	0.00129	CcSEcCtD
Trimipramine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000413	0.00129	CcSEcCtD
Trimipramine—Diarrhoea—Pamidronate—osteoporosis	0.000412	0.00129	CcSEcCtD
Trimipramine—Rash—Ethinyl Estradiol—osteoporosis	0.00041	0.00128	CcSEcCtD
Trimipramine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00041	0.00128	CcSEcCtD
Trimipramine—Headache—Ethinyl Estradiol—osteoporosis	0.000407	0.00127	CcSEcCtD
Trimipramine—Vomiting—Risedronate—osteoporosis	0.000403	0.00126	CcSEcCtD
Trimipramine—Rash—Risedronate—osteoporosis	0.0004	0.00125	CcSEcCtD
Trimipramine—Dermatitis—Risedronate—osteoporosis	0.000399	0.00125	CcSEcCtD
Trimipramine—Dizziness—Pamidronate—osteoporosis	0.000398	0.00124	CcSEcCtD
Trimipramine—Headache—Risedronate—osteoporosis	0.000397	0.00124	CcSEcCtD
Trimipramine—Asthenia—Zoledronate—osteoporosis	0.000395	0.00123	CcSEcCtD
Trimipramine—Pruritus—Zoledronate—osteoporosis	0.000389	0.00122	CcSEcCtD
Trimipramine—Nausea—Ethinyl Estradiol—osteoporosis	0.000386	0.00121	CcSEcCtD
Trimipramine—Insomnia—Estradiol—osteoporosis	0.000384	0.0012	CcSEcCtD
Trimipramine—Vomiting—Pamidronate—osteoporosis	0.000383	0.0012	CcSEcCtD
Trimipramine—Paraesthesia—Estradiol—osteoporosis	0.000381	0.00119	CcSEcCtD
Trimipramine—Asthenia—Conjugated Estrogens—osteoporosis	0.00038	0.00119	CcSEcCtD
Trimipramine—Rash—Pamidronate—osteoporosis	0.00038	0.00119	CcSEcCtD
Trimipramine—Dermatitis—Pamidronate—osteoporosis	0.00038	0.00118	CcSEcCtD
Trimipramine—Methadone—CYP19A1—osteoporosis	0.000378	0.146	CrCbGaD
Trimipramine—Headache—Pamidronate—osteoporosis	0.000378	0.00118	CcSEcCtD
Trimipramine—Somnolence—Estradiol—osteoporosis	0.000377	0.00118	CcSEcCtD
Trimipramine—Diarrhoea—Zoledronate—osteoporosis	0.000377	0.00118	CcSEcCtD
Trimipramine—Nausea—Risedronate—osteoporosis	0.000377	0.00118	CcSEcCtD
Trimipramine—Pruritus—Conjugated Estrogens—osteoporosis	0.000375	0.00117	CcSEcCtD
Trimipramine—Dyspepsia—Estradiol—osteoporosis	0.000373	0.00117	CcSEcCtD
Trimipramine—Decreased appetite—Estradiol—osteoporosis	0.000369	0.00115	CcSEcCtD
Trimipramine—Fatigue—Estradiol—osteoporosis	0.000366	0.00114	CcSEcCtD
Trimipramine—Dizziness—Zoledronate—osteoporosis	0.000364	0.00114	CcSEcCtD
Trimipramine—Constipation—Estradiol—osteoporosis	0.000363	0.00113	CcSEcCtD
Trimipramine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000363	0.00113	CcSEcCtD
Trimipramine—Nausea—Pamidronate—osteoporosis	0.000358	0.00112	CcSEcCtD
Trimipramine—Dizziness—Conjugated Estrogens—osteoporosis	0.00035	0.00109	CcSEcCtD
Trimipramine—Vomiting—Zoledronate—osteoporosis	0.00035	0.00109	CcSEcCtD
Trimipramine—Feeling abnormal—Estradiol—osteoporosis	0.00035	0.00109	CcSEcCtD
Trimipramine—Rash—Zoledronate—osteoporosis	0.000347	0.00108	CcSEcCtD
Trimipramine—Dermatitis—Zoledronate—osteoporosis	0.000347	0.00108	CcSEcCtD
Trimipramine—Headache—Zoledronate—osteoporosis	0.000345	0.00108	CcSEcCtD
Trimipramine—Vomiting—Conjugated Estrogens—osteoporosis	0.000337	0.00105	CcSEcCtD
Trimipramine—Urticaria—Estradiol—osteoporosis	0.000337	0.00105	CcSEcCtD
Trimipramine—Abdominal pain—Estradiol—osteoporosis	0.000335	0.00105	CcSEcCtD
Trimipramine—Body temperature increased—Estradiol—osteoporosis	0.000335	0.00105	CcSEcCtD
Trimipramine—Rash—Conjugated Estrogens—osteoporosis	0.000334	0.00104	CcSEcCtD
Trimipramine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000334	0.00104	CcSEcCtD
Trimipramine—Headache—Conjugated Estrogens—osteoporosis	0.000332	0.00104	CcSEcCtD
Trimipramine—Nausea—Zoledronate—osteoporosis	0.000327	0.00102	CcSEcCtD
Trimipramine—Nausea—Conjugated Estrogens—osteoporosis	0.000315	0.000983	CcSEcCtD
Trimipramine—Asthenia—Estradiol—osteoporosis	0.000304	0.00095	CcSEcCtD
Trimipramine—Pruritus—Estradiol—osteoporosis	0.0003	0.000937	CcSEcCtD
Trimipramine—Diarrhoea—Estradiol—osteoporosis	0.00029	0.000906	CcSEcCtD
Trimipramine—Dizziness—Estradiol—osteoporosis	0.000281	0.000875	CcSEcCtD
Trimipramine—Vomiting—Estradiol—osteoporosis	0.00027	0.000842	CcSEcCtD
Trimipramine—Rash—Estradiol—osteoporosis	0.000267	0.000835	CcSEcCtD
Trimipramine—Dermatitis—Estradiol—osteoporosis	0.000267	0.000834	CcSEcCtD
Trimipramine—Headache—Estradiol—osteoporosis	0.000266	0.000829	CcSEcCtD
Trimipramine—Nausea—Estradiol—osteoporosis	0.000252	0.000786	CcSEcCtD
Trimipramine—CYP2C19—Metabolism—P4HB—osteoporosis	2.45e-05	0.000239	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	2.42e-05	0.000236	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PSMA2—osteoporosis	2.42e-05	0.000236	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PSMA5—osteoporosis	2.42e-05	0.000236	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PSMA5—osteoporosis	2.41e-05	0.000236	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PSMA2—osteoporosis	2.41e-05	0.000236	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SPP1—osteoporosis	2.41e-05	0.000235	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—TGFB1—osteoporosis	2.4e-05	0.000235	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GAPDH—osteoporosis	2.4e-05	0.000235	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—TPI1—osteoporosis	2.39e-05	0.000234	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—POMC—osteoporosis	2.39e-05	0.000234	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—P4HB—osteoporosis	2.39e-05	0.000233	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—TPI1—osteoporosis	2.37e-05	0.000232	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KL—osteoporosis	2.37e-05	0.000231	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	2.37e-05	0.000231	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	2.37e-05	0.000231	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KL—osteoporosis	2.36e-05	0.00023	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GAPDH—osteoporosis	2.34e-05	0.000229	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—RAP1A—osteoporosis	2.34e-05	0.000228	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	2.33e-05	0.000228	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	2.33e-05	0.000227	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	2.33e-05	0.000227	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—POMC—osteoporosis	2.31e-05	0.000226	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—POMC—osteoporosis	2.3e-05	0.000224	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CALCA—osteoporosis	2.29e-05	0.000224	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—RAP1A—osteoporosis	2.28e-05	0.000223	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—FGB—osteoporosis	2.28e-05	0.000222	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KL—osteoporosis	2.26e-05	0.00022	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL6R—osteoporosis	2.25e-05	0.00022	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CALCA—osteoporosis	2.25e-05	0.00022	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—P4HB—osteoporosis	2.25e-05	0.00022	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CALCA—osteoporosis	2.25e-05	0.000219	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	2.24e-05	0.000219	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—POMC—osteoporosis	2.23e-05	0.000218	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—P4HB—osteoporosis	2.23e-05	0.000218	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CA2—osteoporosis	2.22e-05	0.000217	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—OXCT1—osteoporosis	2.22e-05	0.000217	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GAPDH—osteoporosis	2.21e-05	0.000216	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CALCA—osteoporosis	2.21e-05	0.000215	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—POMC—osteoporosis	2.2e-05	0.000215	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	2.2e-05	0.000215	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	2.2e-05	0.000215	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—POMC—osteoporosis	2.2e-05	0.000215	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—POMC—osteoporosis	2.19e-05	0.000214	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GAPDH—osteoporosis	2.19e-05	0.000214	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IRS2—osteoporosis	2.18e-05	0.000212	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MGLL—osteoporosis	2.17e-05	0.000211	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—RAP1A—osteoporosis	2.15e-05	0.00021	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	2.15e-05	0.00021	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	2.15e-05	0.000209	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CYP19A1—osteoporosis	2.13e-05	0.000208	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—RAP1A—osteoporosis	2.13e-05	0.000208	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—LEP—osteoporosis	2.13e-05	0.000208	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KL—osteoporosis	2.08e-05	0.000203	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	2.05e-05	0.0002	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KL—osteoporosis	2.05e-05	0.0002	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KL—osteoporosis	2.04e-05	0.000199	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.04e-05	0.000199	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ESR1—osteoporosis	2.03e-05	0.000198	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—POMC—osteoporosis	2.03e-05	0.000198	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KL—osteoporosis	2e-05	0.000196	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	2e-05	0.000195	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—POMC—osteoporosis	2e-05	0.000195	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—POMC—osteoporosis	1.99e-05	0.000194	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.98e-05	0.000193	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.95e-05	0.000191	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.95e-05	0.00019	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.94e-05	0.00019	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	1.92e-05	0.000188	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.91e-05	0.000186	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.9e-05	0.000185	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ENO1—osteoporosis	1.89e-05	0.000185	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.86e-05	0.000182	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.86e-05	0.000182	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KL—osteoporosis	1.86e-05	0.000182	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.86e-05	0.000182	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	1.86e-05	0.000182	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.86e-05	0.000181	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ENO1—osteoporosis	1.85e-05	0.00018	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.85e-05	0.00018	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—IDH2—osteoporosis	1.84e-05	0.00018	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—POMC—osteoporosis	1.83e-05	0.000179	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.82e-05	0.000178	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PSMA2—osteoporosis	1.82e-05	0.000178	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PSMA5—osteoporosis	1.82e-05	0.000178	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.82e-05	0.000177	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.79e-05	0.000175	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.79e-05	0.000174	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.78e-05	0.000174	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.77e-05	0.000173	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.77e-05	0.000172	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.76e-05	0.000172	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.74e-05	0.00017	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ENO1—osteoporosis	1.74e-05	0.00017	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GPX1—osteoporosis	1.74e-05	0.00017	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.73e-05	0.000169	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ENO1—osteoporosis	1.72e-05	0.000168	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.71e-05	0.000167	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.71e-05	0.000167	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.71e-05	0.000167	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.7e-05	0.000166	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.7e-05	0.000166	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ACP5—osteoporosis	1.68e-05	0.000164	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.68e-05	0.000164	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.65e-05	0.000161	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.63e-05	0.000159	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.62e-05	0.000158	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.61e-05	0.000158	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—MTHFR—osteoporosis	1.6e-05	0.000157	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.6e-05	0.000156	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.6e-05	0.000156	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—LEP—osteoporosis	1.59e-05	0.000155	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.58e-05	0.000154	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.58e-05	0.000154	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.57e-05	0.000153	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.57e-05	0.000153	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TPI1—osteoporosis	1.57e-05	0.000153	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.55e-05	0.000151	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SPP1—osteoporosis	1.55e-05	0.000151	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.55e-05	0.000151	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.52e-05	0.000148	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.52e-05	0.000148	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.51e-05	0.000148	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.51e-05	0.000148	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.51e-05	0.000147	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.48e-05	0.000144	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—P4HB—osteoporosis	1.47e-05	0.000144	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.47e-05	0.000143	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.46e-05	0.000142	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.44e-05	0.000141	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.44e-05	0.000141	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.43e-05	0.000139	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.42e-05	0.000138	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.41e-05	0.000138	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.41e-05	0.000138	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.41e-05	0.000138	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.41e-05	0.000137	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.4e-05	0.000137	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IRS2—osteoporosis	1.4e-05	0.000137	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—LEP—osteoporosis	1.39e-05	0.000136	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.39e-05	0.000136	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.38e-05	0.000135	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.38e-05	0.000135	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.37e-05	0.000134	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.37e-05	0.000134	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—LEP—osteoporosis	1.37e-05	0.000134	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—POMC—osteoporosis	1.36e-05	0.000133	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.36e-05	0.000133	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.36e-05	0.000133	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.35e-05	0.000132	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.35e-05	0.000131	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.34e-05	0.000131	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ESR1—osteoporosis	1.33e-05	0.00013	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.33e-05	0.00013	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.32e-05	0.000129	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.31e-05	0.000128	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.31e-05	0.000128	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ESR1—osteoporosis	1.31e-05	0.000128	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.31e-05	0.000127	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.3e-05	0.000127	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.28e-05	0.000125	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—POMC—osteoporosis	1.28e-05	0.000125	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.28e-05	0.000125	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.27e-05	0.000124	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.25e-05	0.000122	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.25e-05	0.000122	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IRS1—osteoporosis	1.24e-05	0.000121	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ADCY5—osteoporosis	1.24e-05	0.000121	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GPX1—osteoporosis	1.23e-05	0.00012	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.22e-05	0.00012	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IRS1—osteoporosis	1.22e-05	0.000119	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ADCY5—osteoporosis	1.21e-05	0.000118	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GPX1—osteoporosis	1.2e-05	0.000117	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.2e-05	0.000117	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—POMC—osteoporosis	1.2e-05	0.000117	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.19e-05	0.000116	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—POMC—osteoporosis	1.18e-05	0.000115	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—POMC—osteoporosis	1.18e-05	0.000115	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6R—osteoporosis	1.17e-05	0.000114	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.15e-05	0.000113	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IGF1—osteoporosis	1.15e-05	0.000113	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.15e-05	0.000112	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6R—osteoporosis	1.15e-05	0.000112	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ENO1—osteoporosis	1.14e-05	0.000111	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.14e-05	0.000111	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—MTHFR—osteoporosis	1.14e-05	0.000111	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.13e-05	0.000111	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GPX1—osteoporosis	1.13e-05	0.000111	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IGF1—osteoporosis	1.13e-05	0.00011	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ADCY5—osteoporosis	1.13e-05	0.00011	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.13e-05	0.00011	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GPX1—osteoporosis	1.12e-05	0.00011	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.12e-05	0.000109	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.12e-05	0.000109	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.11e-05	0.000109	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.11e-05	0.000108	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—MTHFR—osteoporosis	1.11e-05	0.000108	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.07e-05	0.000105	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MYC—osteoporosis	1.06e-05	0.000103	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TGFB1—osteoporosis	1.05e-05	0.000103	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.05e-05	0.000102	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—MTHFR—osteoporosis	1.05e-05	0.000102	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	1.04e-05	0.000102	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—MTHFR—osteoporosis	1.04e-05	0.000101	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.03e-05	0.000101	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL6—osteoporosis	1e-05	9.8e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL6—osteoporosis	9.99e-06	9.75e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	9.56e-06	9.33e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.09e-06	8.88e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—POMC—osteoporosis	9.09e-06	8.87e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—POMC—osteoporosis	8.87e-06	8.66e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—osteoporosis	8.81e-06	8.6e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—osteoporosis	8.67e-06	8.47e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—osteoporosis	8.65e-06	8.45e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	8.49e-06	8.29e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—POMC—osteoporosis	8.36e-06	8.16e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—POMC—osteoporosis	8.29e-06	8.09e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—osteoporosis	8.17e-06	7.98e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	8.15e-06	7.96e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—osteoporosis	7.95e-06	7.76e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	7.89e-06	7.7e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—osteoporosis	7.89e-06	7.7e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	7.87e-06	7.68e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—osteoporosis	7.85e-06	7.66e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	7.83e-06	7.64e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—osteoporosis	7.51e-06	7.33e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	7.49e-06	7.32e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ADCY5—osteoporosis	7.43e-06	7.25e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GPX1—osteoporosis	7.4e-06	7.23e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—osteoporosis	6.93e-06	6.76e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TGFB1—osteoporosis	6.91e-06	6.74e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MTHFR—osteoporosis	6.83e-06	6.67e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—osteoporosis	6.81e-06	6.65e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—osteoporosis	6.8e-06	6.64e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	6.8e-06	6.64e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TGFB1—osteoporosis	6.78e-06	6.62e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—osteoporosis	6.67e-06	6.51e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	6.66e-06	6.5e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—osteoporosis	6.2e-06	6.05e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	6.18e-06	6.04e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—osteoporosis	6.14e-06	6e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—osteoporosis	5.93e-06	5.79e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—osteoporosis	5.9e-06	5.76e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—osteoporosis	5.65e-06	5.51e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—POMC—osteoporosis	5.46e-06	5.33e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—osteoporosis	5.21e-06	5.08e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—osteoporosis	5.12e-06	5e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—osteoporosis	5.11e-06	4.99e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—osteoporosis	5.02e-06	4.9e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—osteoporosis	4.66e-06	4.55e-05	CbGpPWpGaD
